Repair & Recovery.
The repair bench: BPC-157 and TB500 in two strengths each, plus GHK-Cu, LL-37 and ACE-031. Worth knowing before you order that the animal literature behind this group is substantial and the human literature is thin — both halves are true and we would rather you heard it here.
Worth reading first
ImmuneLL-37 and cathelicidin: what the human studies measured
Human LL-37 is measurable in blood and in tissue, tracks with infection severity in some cohorts, and has never been given to a human as a therapy in a trial that printed a result. This page reads four papers, three of them in people and one in mice.
RepairACE-031: what the human myostatin trial measured
The class has one human myostatin-inhibition trial in Duchenne muscular dystrophy. It was stopped after the second dose regimen because of epistaxis and telangiectasias, and every efficacy result in it was a non-significant trend.
RecoveryBPC-157 in humans: the whole corpus, counted
Three pilot studies: twelve women with bladder pain, sixteen knee patients surveyed by phone, and two people having an infusion. The rest is rat.